mesothelioma pleural

Malignant m soth liome p riton al isn oplasmer sultant lining serosal etpericardic cavitiesp riton ales. The primary education tumours resulting from them soth liomep riton al are extremely rare. The precise diagnosisdum soth liome diffuse p riton al is important because it hasmortals results presqueinvariablement. In much of case,lem soth liome p riton al malignant is not diagnosed untilapr s the surgery or with the autopsy. The distinction of themalignant m soth liomep riton al of the tumours metastatic to themembranes serosal peutsouvent being made based on the results ofstudies.

Thehistochimic that the majority of the commonsymptoms of the malignant m soth liomep riton al are difficulty inbreathing, of pain decoffre, or both. Other symptoms include thepertede weight, fever, night sweat, cough, and a general feeling nepasto be well, although these symptoms are not as traitementstandard ofcommon.

The for the m soth liome p riton almalin is notcurative. The aggressive treatment will make it possiblequelquespatients to test long-term survival, but it is still topeuclair if total rates of survival would be appreciably changedpardiff rents treatments or combinations of the treatments. It yadiff rents treatments available for the malignantm soth liomep riton al, depend on the state of its diagnosis.Pourl' stage one, it is m soth liome p riton al malignantlocalised, standard destraitements are m soth liome p riton almalignant, lem soth liome intracavitary, chemotherapy intracavitaryapr sles stages of resection.

For 2 to 4, which ism soth liomep riton al malignant advanced, of the treatmentsavailable sonttraitement symptomatic to include the drainage ofoverflowings, pleurodesis of tube of trunk, or the pleurodesisthoracoscopic, palliative surgical lar section in the patientschosen, palliative radiation therapy, chemotherapy of simple-agent,etdate clinical of the multimodality trials.

To, theresontaucune approach of treatment who were shown for am liorerlasurvival or to order symptoms during one p riodeprolong e. But withadvance in the field of the technologieet of medicine, there is hopethat a certain day, will m decinspourrez to demolish the tumour andto leave with a certain desauvetage treatment against thistumor.